These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7628338)
1. [Arguments for early treatment of refractory schizophrenia]. Lombertie ER; Salome N; Villegier P; Laghrissi-Thode F; Nassif F Encephale; 1995 Jun; 21 Spec No 3():29-33. PubMed ID: 7628338 [TBL] [Abstract][Full Text] [Related]
2. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771 [TBL] [Abstract][Full Text] [Related]
3. [Treatment refractory schizophrenia]. Vanelle JM Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336 [TBL] [Abstract][Full Text] [Related]
4. [Quality of life of schizophrenic patients and clozapine]. Raoul Y; Manesse P; Delage M Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398 [TBL] [Abstract][Full Text] [Related]
5. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. al-Semaan Y Can J Psychiatry; 1996 Sep; 41(7):484-5. PubMed ID: 8884041 [No Abstract] [Full Text] [Related]
6. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Zink M; Knopf U; Henn FA; Thome J Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045 [TBL] [Abstract][Full Text] [Related]
7. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?]. Hornung WP; Buchkremer G; Redbrake M; Klingberg S Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569 [TBL] [Abstract][Full Text] [Related]
9. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Cook B; Hoogenboom G Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745 [TBL] [Abstract][Full Text] [Related]
10. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. Kopala LC; Fredrikson D; Good KP; Honer WG Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777 [No Abstract] [Full Text] [Related]
12. Management of treatment resistant schizophrenia unresponsive to clozapine. Barnes TR; McEvedy CJ; Nelson HE Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653 [No Abstract] [Full Text] [Related]
13. [Weight gain and clozapine]. Jalenques I; Tauveron I; Albuisson E; Audy V Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282 [No Abstract] [Full Text] [Related]
14. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine]. Stengler-Wenzke K Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713 [TBL] [Abstract][Full Text] [Related]
16. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine. Friedman J; Ault K; Powchik P Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089 [No Abstract] [Full Text] [Related]
18. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
19. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group. Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652 [No Abstract] [Full Text] [Related]